 Ginkgo Bioworks Holdings Inc NYSE: DNA shares are trading higher by 22.0 at 4.56 after the company reported better-than-expected fourth-quarter sales results and issued FY22 sales guidance above analyst estimates. Ginkgo Bioworks reported quarterly sales of 148.00 million which beat the. 